Melanoma patients who responded to anti-PD-1 therapy had a higher abundance of B. longum, C. aerofaciens, and E. faeciumGerm-free mice transplanted with fecal material from responding patients could lead to improved tumor control, augmented T cell responses, and greater efficacy of anti-PD-L1 therapy. The gene discussed is PDCD1; the disease is neoplasm.